What Connects Cleft Lip and CDH1 Stomach Cancer?
At a Glance
The CDH1 gene provides instructions for E-cadherin, a cellular glue. A mutation in this gene can prevent fetal facial tissues from fusing, causing a cleft lip or palate. This same missing glue later allows stomach and breast cells to break loose, causing hereditary diffuse gastric cancer.
In this answer
4 sections
It can seem confusing when a doctor or genetic counselor asks about facial birth defects during a discussion about stomach cancer. The connection between a cleft lip or palate and stomach cancer lies in a single genetic mutation that affects how the cells in our bodies stick to one another [1].
The Role of “Cellular Glue”
To understand this connection, it helps to look at a specific gene called CDH1 (cadherin 1) [2]. Genes are essentially instruction manuals for our bodies. The CDH1 gene provides the instructions for making a crucial protein known as E-cadherin [3][4].
Think of E-cadherin as a heavy-duty cellular glue. It sits on the surface of our cells and binds them tightly to their neighboring cells [1][2][5]. This cellular glue is responsible for maintaining the structure and strength of various tissues in the body, ensuring that cells stay exactly where they belong [3][6].
When a person has a mutation (a typo in the instruction manual) in their CDH1 gene, their body either does not produce enough E-cadherin or produces a defective version of it [7][1]. This loss of cellular glue has distinct effects depending on where and when it happens in the body [8][1].
How Missing Glue Affects Fetal Development
When a fetus is developing during pregnancy, various tissues must migrate and fuse together perfectly to form the face [2][5]. E-cadherin is essential for this delicate process. The cellular glue ensures that the tissues making up the upper lip and the roof of the mouth (the palate) successfully attach to one another [5][9].
If a baby inherits a mutated CDH1 gene, the lack of functioning E-cadherin can prevent these facial tissues from fusing completely [2][9]. This failure to connect results in an opening or split in the upper lip or the roof of the mouth—a condition known as a cleft lip or cleft palate [2][10]. Because this happens during fetal development, the cleft lip or palate is present at birth.
How Missing Glue Leads to Diffuse Cancers
That exact same cellular glue is also heavily relied upon by the cells lining the stomach and, in women, the milk-producing lobules of the breast [1][11]. In a healthy body, E-cadherin keeps these cells tightly packed together in an organized, protective layer [12][13].
When the CDH1 mutation causes a loss of this glue, the cells lose their grip on one another [7]. Without that structural connection, individual cells can break away from their designated tissue, grow uncontrollably, and invade the surrounding area [7][14].
In the stomach, this process causes Hereditary Diffuse Gastric Cancer (HDGC), a rare and aggressive form of cancer where tumors grow in tiny, loose clusters throughout the stomach wall rather than forming a single, solid lump [2][11][7]. Because it grows diffusely, it is notoriously difficult to spot during a standard endoscopy. In the breasts, this same loss of glue allows cells to break away and form lobular breast cancer [2][11].
Why Genetic Counselors Look for This Clue
Because an altered CDH1 gene can cause both a cleft lip at birth and stomach or breast cancer later in life, the presence of a cleft lip in your family tree acts as a critical red flag for geneticists [2][11]. Identifying this visible, developmental clue helps them piece together a family’s silent genetic risk for cancer, allowing for earlier screening and life-saving interventions [15][16].
However, it is vital to keep two things in perspective:
- Most people with CDH1 mutations do not have a cleft lip, nor do they have a family history of one [2]. If no one in your family has had a cleft lip, it does not mean your cancer risk or diagnosis is incorrect.
- A cleft lip does not mean the cancer will be worse. If a family member does have a cleft lip, it simply points to the same underlying genetic mutation. It does not mean their cancer risk is more severe or aggressive than someone with the mutation who does not have a cleft lip [17][2].
If you have been diagnosed with a CDH1 mutation and recognize this pattern of cleft lip or palate in your extended family, it is important to inform your relatives. A cousin with a history of a cleft palate might not know they need to be screened for stomach or breast cancer [15].
Common questions in this guide
Why do genetic counselors ask about cleft lip when screening for stomach cancer?
Does having a cleft lip mean my stomach cancer will be worse?
What happens if no one in my family has a cleft lip, but I have a CDH1 mutation?
Should I tell my family members with a cleft lip about my CDH1 mutation?
Why is CDH1 stomach cancer difficult to detect on an endoscopy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Does my specific CDH1 mutation have a known association with cleft lip and palate in other families?
- 2.Since my family does not have a history of cleft lip, does that tell us anything about the specific region or behavior of my CDH1 mutation?
- 3.Should I notify extended family members who were born with a cleft lip or palate about my genetic test results?
- 4.Given that the lack of E-cadherin causes diffuse cancer growth, how does your screening plan account for tumors that are difficult to see on standard endoscopy?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (17)
- 1
CDH1 and hereditary diffuse gastric cancer: a narrative review.
Gregory SN, Davis JL
Chinese clinical oncology 2023; (12(3)):25 doi:10.21037/cco-23-36.
PMID: 37303221 - 2
First report of a Mexican family with mutation in the CDH1 gene.
Martínez Valenzuela C, Castelán-Maldonado EE, Carvajal-Zarrabal O, Calderón-Garcidueñas AL
Molecular genetics & genomic medicine 2020; (8(11)):e1208 doi:10.1002/mgg3.1208.
PMID: 32886433 - 3
E-cadherin staining in the diagnosis of lobular versus ductal neoplasms of the breast: the emperor has no clothes.
Taha SR, Boulos F
Histopathology 2025; (86(3)):327-340 doi:10.1111/his.15295.
PMID: 39138705 - 4
E-cadherin integrates mechanotransduction and EGFR signaling to control junctional tissue polarization and tight junction positioning.
Rübsam M, Mertz AF, Kubo A, et al.
Nature communications 2017; (8(1)):1250 doi:10.1038/s41467-017-01170-7.
PMID: 29093447 - 5
Blepharocheilodontic syndrome is a CDH1 pathway-related disorder due to mutations in CDH1 and CTNND1.
Ghoumid J, Stichelbout M, Jourdain AS, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2017; (19(9)):1013-1021 doi:10.1038/gim.2017.11.
PMID: 28301459 - 6
A central role for cadherin signaling in cancer.
Kourtidis A, Lu R, Pence LJ, Anastasiadis PZ
Experimental cell research 2017; (358(1)):78-85 doi:10.1016/j.yexcr.2017.04.006.
PMID: 28412244 - 7
Inherited CDH1 pathogenic variant: is there a place for surveillance of esophageal gastric inlet patch?
Leclercq P, Jadot V, Bours V, et al.
Therapeutic advances in gastroenterology 2020; (13()):1756284820916399 doi:10.1177/1756284820916399.
PMID: 32523621 - 8
E-cadherin variants associated with oral facial clefts trigger aberrant cell motility in a REG1A-dependent manner.
Pereira J, Melo S, Ferreira RM, et al.
Cell communication and signaling : CCS 2024; (22(1)):152 doi:10.1186/s12964-024-01532-x.
PMID: 38414029 - 9
Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
Obermair F, Rammer M, Burghofer J, et al.
Familial cancer 2019; (18(2)):253-260 doi:10.1007/s10689-018-0111-5.
PMID: 30306390 - 10
Prognosis and outcome in CDH1-mutant lobular breast cancer.
Corso G, Veronesi P, Sacchini V, Galimberti V
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(3)):237-238 doi:10.1097/CEJ.0000000000000405.
PMID: 29595757 - 11
Clinical spectrum and pleiotropic nature of CDH1 germline mutations.
Figueiredo J, Melo S, Carneiro P, et al.
Journal of medical genetics 2019; (56(4)):199-208 doi:10.1136/jmedgenet-2018-105807.
PMID: 30661051 - 12
Loss of E-Cadherin Alters Cigarette Smoke Extract (CSE)-Induced Damage and Repair Responses in Human Airway Epithelial Cells; Implications for Chronic Obstructive Pulmonary Disease (COPD).
Zheng X, Nwozor KO, Jonker M, et al.
Molecular and cellular biology 2025; (45(11)):481-494 doi:10.1080/10985549.2025.2560946.
PMID: 41020432 - 13
Cell division-dependent dissemination following E-cadherin loss underlies initiation of diffuse-type gastric cancer.
Monster JL, Kemp LJ, Busslinger GA, et al.
The Journal of pathology 2024; (263(2)):226-241 doi:10.1002/path.6277.
PMID: 38572612 - 14
Significance of E-cadherin Gene Mutations in Patients With Hereditary Diffuse Gastric Cancer Syndrome: A Systematic Review.
Goud HK, Mehkari Z, Mohammed L, et al.
Cureus 2020; (12(9)):e10406 doi:10.7759/cureus.10406.
PMID: 33062523 - 15
Diagnosis and Management of Hereditary Gastric Cancer.
Monahan KJ, Hopkins L
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer 2016; (205()):45-60 doi:10.1007/978-3-319-29998-3_4.
PMID: 27075348 - 16
Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer.
van der Kaaij RT, van Kessel JP, van Dieren JM, et al.
The British journal of surgery 2018; (105(2)):e176-e182 doi:10.1002/bjs.10754.
PMID: 29341148 - 17
CDH1 Mutation Distribution and Type Suggests Genetic Differences between the Etiology of Orofacial Clefting and Gastric Cancer.
Selvanathan A, Nixon CY, Zhu Y, et al.
Genes 2020; (11(4)) doi:10.3390/genes11040391.
PMID: 32260281
This information about CDH1 mutations and cancer risk is for educational purposes only. Always consult a genetic counselor or oncologist for personalized medical advice and screening plans.
Get notified when new evidence is published on Hereditary diffuse gastric cancer.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.